Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
BCL2 expression
i
Other names:
BCL2, Bcl-2, PPP1R50, B-cell CLL/lymphoma 2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
596
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
BCL2 expression
Diffuse Large B Cell Lymphoma
BCL2 expression
Diffuse Large B Cell Lymphoma
venetoclax + obinutuzumab
Sensitive: C2 – Inclusion Criteria
venetoclax + obinutuzumab
Sensitive
:
C2
venetoclax + obinutuzumab
Sensitive: C2 – Inclusion Criteria
venetoclax + obinutuzumab
Sensitive
:
C2
BCL2 expression
Acute Myelogenous Leukemia
BCL2 expression
Acute Myelogenous Leukemia
venetoclax
Sensitive: C2 – Inclusion Criteria
venetoclax
Sensitive
:
C2
venetoclax
Sensitive: C2 – Inclusion Criteria
venetoclax
Sensitive
:
C2
BCL2 expression
Non-Hodgkin’s Lymphoma
BCL2 expression
Non-Hodgkin’s Lymphoma
venetoclax
Sensitive: C2 – Inclusion Criteria
venetoclax
Sensitive
:
C2
venetoclax
Sensitive: C2 – Inclusion Criteria
venetoclax
Sensitive
:
C2
BCL2 expression
Diffuse Large B Cell Lymphoma
BCL2 expression
Diffuse Large B Cell Lymphoma
lenalidomide
Sensitive: C2 – Inclusion Criteria
lenalidomide
Sensitive
:
C2
lenalidomide
Sensitive: C2 – Inclusion Criteria
lenalidomide
Sensitive
:
C2
BCL2 expression
Hodgkin Lymphoma
BCL2 expression
Hodgkin Lymphoma
Resistant: C3 – Early Trials
Resistant
:
C3
Resistant: C3 – Early Trials
Resistant
:
C3
BCL2 expression
Hodgkin Lymphoma
BCL2 expression
Hodgkin Lymphoma
venetoclax
Sensitive: D – Preclinical
venetoclax
Sensitive
:
D
venetoclax
Sensitive: D – Preclinical
venetoclax
Sensitive
:
D
BCL2 expression
Diffuse Large B Cell Lymphoma
BCL2 expression
Diffuse Large B Cell Lymphoma
venetoclax + S63845
Sensitive: D – Preclinical
venetoclax + S63845
Sensitive
:
D
venetoclax + S63845
Sensitive: D – Preclinical
venetoclax + S63845
Sensitive
:
D
BCL2 expression
Diffuse Large B Cell Lymphoma
BCL2 expression
Diffuse Large B Cell Lymphoma
S63845
Resistant: D – Preclinical
S63845
Resistant
:
D
S63845
Resistant: D – Preclinical
S63845
Resistant
:
D
BCL2 expression
Multiple Myeloma
BCL2 expression
Multiple Myeloma
S63845
Sensitive: D – Preclinical
S63845
Sensitive
:
D
S63845
Sensitive: D – Preclinical
S63845
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login